SLC responds to A17: slcimmuno Member Level S
Post# of 72440
(Total Views: 322)
Posted On: 05/14/2017 3:31:35 PM
Re: someconcerns #33776
SLC responds to A17:
slcimmuno Member Level Sunday, 05/14/17 02:35:46 PM
Re: Amatuer17 post# 181929
Post # of 181950
Fair answer - science + Mngmt matters.
But lest we forget, it's not exactly been an even playing field. Mako et al did a good one on share price (100m drop in a day) and also planted seeds of doubt in many retail investors minds. That we won the Class Action on the merits was nice to see even if Failla copped out on awarding sanctions.
Stock destruction (short/distort) goes hand-in-hand with stock promotion (pump/dump).
I do think Dr Bertolino has been a great add and will yield results. He likely knows how to prep and package the clinical trials so they pass muster in Big Rx eyes. With his past Emp at Novartis and Pfizer. And thing is--we're approaching that crucial tipping point.
Place your bets.
I think both Prurisol and Brilacidin can deliver (K need to see more data, oral formulation) as they currently are in P2s. And if they eat into the sacred but so very costly Biologics turf, then all of us Long-suffering shareholders will be rewarded.
slcimmuno Member Level Sunday, 05/14/17 02:35:46 PM
Re: Amatuer17 post# 181929
Post # of 181950
Fair answer - science + Mngmt matters.
But lest we forget, it's not exactly been an even playing field. Mako et al did a good one on share price (100m drop in a day) and also planted seeds of doubt in many retail investors minds. That we won the Class Action on the merits was nice to see even if Failla copped out on awarding sanctions.
Stock destruction (short/distort) goes hand-in-hand with stock promotion (pump/dump).
I do think Dr Bertolino has been a great add and will yield results. He likely knows how to prep and package the clinical trials so they pass muster in Big Rx eyes. With his past Emp at Novartis and Pfizer. And thing is--we're approaching that crucial tipping point.
Place your bets.
I think both Prurisol and Brilacidin can deliver (K need to see more data, oral formulation) as they currently are in P2s. And if they eat into the sacred but so very costly Biologics turf, then all of us Long-suffering shareholders will be rewarded.
(1)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼